Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
BMC Microbiology|July 16, 2009
Yersinia outer protein YopE affects the actin cytoskeleton in Dictyostelium discoideum through targeting of multiple Rho family GTPasesGeorgia Vlahou, Oxana Schmidt, Bettina Wagner, et al.Oncotarget|July 1, 2016
The posterior HOXD locus: Its contribution to phenotype and malignancy of Ewing sarcomaKristina von Heyking, Laura Roth, Miriam Ertl, et al.Oncotarget|December 2, 2015
Targeting the EWS-ETS transcriptional program by BET bromodomain inhibition in Ewing sarcomaTim Hensel, Chiara Giorgi, Oxana Schmidt, et al.Experimental Cell Research|September 9, 2018
Matrix mineralization controls gene expression in osteoblastic cellsJohannes Wischmann, Florian Lenze, Antonia Thiel, et al.Molecular Oncology|March 21, 2017
The endochondral bone protein CHM1 sustains an undifferentiated, invasive phenotype, promoting lung metastasis in Ewing sarcomaKristina von Heyking, Julia Calzada-Wack, Stefanie Göllner, et al.Journal of Experimental & Clinical Cancer Research : CR|October 16, 2021
Class I histone deacetylases (HDAC) critically contribute to Ewing sarcoma pathogenesisOxana Schmidt, Nadja Nehls, Carolin Prexler, et al.Oncoimmunology|July 30, 2016
Transgenic antigen-specific, HLA-A*02:01-allo-restricted cytotoxic T cells recognize tumor-associated target antigen STEAP1 with high specificityDavid Schirmer, Thomas G P Grünewald, Richard Klar, et al.Cancers|February 5, 2020
Combined Inhibition of Epigenetic Readers and Transcription Initiation Targets the EWS-ETS Transcriptional Program in Ewing SarcomaGünther H S Richter, Tim Hensel, Oxana Schmidt, et al.Oncoimmunology|June 23, 2017
Ewing sarcoma partial regression without GvHD by chondromodulin-I/HLA-A*02:01-specific allorestricted T cell receptor transgenic T cellsUwe Thiel, Sebastian J Schober, Ingo Einspieler, et al.Pageof 1